{"id":4957,"date":"2026-10-26T07:41:46","date_gmt":"2026-10-26T03:41:46","guid":{"rendered":"https:\/\/silkaesthetic.ge\/?p=4957"},"modified":"2026-10-26T07:41:46","modified_gmt":"2026-10-26T03:41:46","slug":"rf-microneedling","status":"publish","type":"post","link":"https:\/\/silkaesthetic.ge\/en\/rf-microneedling\/","title":{"rendered":"What should we know about RF microneedling?"},"content":{"rendered":"

<\/p>\n

\n
\n\"Conceptual
Heating on the RF side is illustrative. The diagram establishes neither a safe depth nor a boundary for heat spread.<\/figcaption><\/figure>\n

Sources reviewed: 25 October 2026.<\/p>\n

Reading time: 2 min.<\/p>\n

What is the most important safety information?<\/h2>\n

On 15 October 2025, the FDA warned of reported burns, scarring, fat loss, disfigurement and nerve damage with certain RF microneedling uses. Some cases required medical or surgical intervention.<\/p>\n

Source: FDA \u2014 RF microneedling safety communication, 15 October 2025<\/a><\/p>\n

How does RF differ from conventional microneedling?<\/h2>\n

RF microneedling needles deliver radiofrequency energy, heating tissue locally. It differs from conventional microneedling and surface RF.<\/p>\n

Source: FDA \u2014 RF microneedling safety communication, 15 October 2025<\/a>; AAD \u2014 Microneedling can fade scars, uneven skin tone, and more<\/a><\/p>\n

What might the procedure be intended to address?<\/h2>\n

FDA authorization concerns a specific device, indication and body site\u2014not every RF model in a catalogue.<\/p>\n

Source: FDA \u2014 Microneedling Devices<\/a><\/p>\n

Why does mentioning collagen not guarantee rejuvenation?<\/h2>\n

Microneedling stimulates a skin-repair response and collagen production. That mechanism does not guarantee an individual result.<\/p>\n

Source: AAD \u2014 Microneedling can fade scars, uneven skin tone, and more<\/a><\/p>\n

What other unwanted reactions are possible?<\/h2>\n

Possible reactions include redness, discomfort, dryness, bleeding, infection and pigmentation changes. A suspected complication needs medical assessment.<\/p>\n

Source: FDA \u2014 Microneedling Devices<\/a><\/p>\n

Who should assess suitability?<\/h2>\n

The TGA notes that penetrating skin carries greater risk than superficial exfoliation. Qualified assessment is needed, particularly with damaged or infected skin.<\/p>\n

Source: TGA \u2014 Microneedling: Things to consider<\/a><\/p>\n

Why is this not a home procedure?<\/h2>\n

The FDA regards RF microneedling as a medical procedure and advises against home use.<\/p>\n

Source: FDA \u2014 RF microneedling safety communication, 15 October 2025<\/a><\/p>\n

What should we know about cartridges and added products?<\/h2>\n

The FDA warns against cartridge reuse, even after cleaning. Devices are not authorized to deliver cosmetics, vitamins, medicines or blood products into skin.<\/p>\n

Source: FDA \u2014 Microneedling Devices<\/a><\/p>\n

What does a safety communication mean?<\/h2>\n

Adverse-event reports justify taking a risk seriously, but the list alone cannot tell us how frequently each problem occurs. That needs additional information, including numbers of procedures and the assessment method. We should neither hide the warning nor derive unsupported rates from it. People deserve accurate information about both known risks and remaining uncertainties.<\/p>\n

How can we set realistic expectations?<\/h2>\n

During consultation, list the main concern, desired change and risks you consider unacceptable. Ask about alternatives and whether the procedure could be postponed or not performed. The choice should not depend only on the possible size of improvement. Consider what complications would mean to you, aftercare needs and access to help. Consent should be informed, not based solely on popularity or a discount.<\/p>\n